RIVASTIGMINE

RIVASTIGMINE was reported 19010 times

These side effects are most commonly reported by patients taking RIVASTIGMINE:

# Side effect Count
0 DEATH 2339
1 FALL 1792
2 HALLUCINATION 1478
3 CONFUSIONAL STATE 1331
4 DRUG INEFFECTIVE 968
5 VOMITING 914
6 NAUSEA 869
7 DIZZINESS 820
8 GAIT DISTURBANCE 751
9 PNEUMONIA 728
10 SOMNOLENCE 693
11 FATIGUE 683
12 MALAISE 679
13 DIARRHOEA 665
14 CONDITION AGGRAVATED 655
15 URINARY TRACT INFECTION 653
16 ASTHENIA 644
17 TREMOR 608
18 PARKINSON^S DISEASE 602
19 WEIGHT DECREASED 602
20 MEMORY IMPAIRMENT 599
21 GENERAL PHYSICAL HEALTH DETERIORATION 580
22 DEMENTIA 578
23 OFF LABEL USE 577
24 AGITATION 552
25 AGGRESSION 532
26 DECREASED APPETITE 512
27 COGNITIVE DISORDER 476
28 INSOMNIA 468
29 CEREBROVASCULAR ACCIDENT 456
30 DYSKINESIA 456
31 DYSPHAGIA 450
32 DYSPNOEA 419
33 HALLUCINATION, VISUAL 413
34 HYPOTENSION 413
35 ANXIETY 405
36 CONSTIPATION 405
37 DRUG INTERACTION 403
38 SYNCOPE 402
39 ON AND OFF PHENOMENON 381
40 ABNORMAL BEHAVIOUR 375
41 DEHYDRATION 369
42 LOSS OF CONSCIOUSNESS 369
43 SPEECH DISORDER 363
44 DISORIENTATION 355
45 MOBILITY DECREASED 352
46 BALANCE DISORDER 335
47 HYPERTENSION 324
48 DELIRIUM 322
49 DELUSION 316
50 DEMENTIA ALZHEIMER^S TYPE 315
51 FEELING ABNORMAL 315
52 PYREXIA 310
53 HEADACHE 309
54 DEPRESSION 308
55 PAIN 302
56 PRODUCT ADHESION ISSUE 299
57 MUSCLE RIGIDITY 295
58 RESTLESSNESS 281
59 BRADYCARDIA 280
60 PRODUCT DOSE OMISSION ISSUE 276
61 APPLICATION SITE ERYTHEMA 274
62 FREEZING PHENOMENON 257
63 PRURITUS 249
64 MUSCULOSKELETAL STIFFNESS 243
65 RASH 233
66 ABDOMINAL PAIN 229
67 ANAEMIA 224
68 BRADYKINESIA 221
69 DEVICE ISSUE 209
70 CARDIAC ARREST 208
71 HYPERHIDROSIS 207
72 ERYTHEMA 206
73 PRODUCT USE IN UNAPPROVED INDICATION 202
74 HIP FRACTURE 200
75 MUSCULAR WEAKNESS 200
76 APPLICATION SITE PRURITUS 197
77 MYOCARDIAL INFARCTION 194
78 UNEVALUABLE EVENT 192
79 STOMA SITE DISCHARGE 191
80 BLOOD PRESSURE INCREASED 190
81 PNEUMONIA ASPIRATION 189
82 HYPOPHAGIA 182
83 PAIN IN EXTREMITY 182
84 OEDEMA PERIPHERAL 179
85 APHASIA 173
86 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 171
87 DEVICE DISLOCATION 170
88 URINARY INCONTINENCE 168
89 OVERDOSE 167
90 AMNESIA 166
91 RENAL FAILURE 166
92 DISTURBANCE IN ATTENTION 165
93 SLEEP DISORDER 165
94 INFECTION 163
95 DEMENTIA ALZHEIMER'S TYPE 160
96 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 159
97 MUSCLE SPASMS 159
98 PSYCHOTIC DISORDER 159
99 COUGH 158
100 ACUTE KIDNEY INJURY 157
101 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 157
102 ORTHOSTATIC HYPOTENSION 156
103 SEIZURE 154
104 CARDIAC FAILURE 153
105 SEPSIS 153
106 ABNORMAL DREAMS 152
107 DRUG INTOLERANCE 151
108 PERIPHERAL SWELLING 151
109 HEAD INJURY 149
110 UNRESPONSIVE TO STIMULI 148
111 ATRIAL FIBRILLATION 146
112 BLOOD PRESSURE DECREASED 146
113 STOMA SITE ERYTHEMA 146
114 ABDOMINAL PAIN UPPER 145
115 INCORRECT DOSE ADMINISTERED 144
116 CARDIO-RESPIRATORY ARREST 143
117 GAIT INABILITY 143
118 GASTROINTESTINAL HAEMORRHAGE 142
119 PARANOIA 142
120 RESPIRATORY FAILURE 142
121 ABDOMINAL DISCOMFORT 141
122 DYSSTASIA 140
123 DEPRESSED LEVEL OF CONSCIOUSNESS 138
124 CHEST PAIN 137
125 ARTHRALGIA 135
126 FEMUR FRACTURE 135
127 BACK PAIN 134
128 ABASIA 131
129 HYPERSENSITIVITY 131
130 HYPERSOMNIA 131
131 COVID-19 130
132 CONVULSION 129
133 LETHARGY 129
134 WEIGHT INCREASED 129
135 HYPOKINESIA 128
136 MOVEMENT DISORDER 128
137 PRODUCT USE ISSUE 128
138 ARRHYTHMIA 125
139 HYPONATRAEMIA 125
140 DISEASE PROGRESSION 124
141 PARKINSONISM 124
142 TOXICITY TO VARIOUS AGENTS 124
143 UNDERDOSE 124
144 URINARY RETENTION 124
145 DYSTONIA 123
146 HOSPITALISATION 120
147 HYPERKINESIA 119
148 CARDIAC DISORDER 118
149 NIGHTMARE 118
150 PULMONARY EMBOLISM 117
151 DYSARTHRIA 112
152 GASTROINTESTINAL DISORDER 111
153 DEPRESSED MOOD 108
154 DIABETES MELLITUS 108
155 TRANSIENT ISCHAEMIC ATTACK 108
156 APPLICATION SITE RASH 106
157 ABDOMINAL DISTENSION 104
158 CONTUSION 103
159 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 102
160 HAEMOGLOBIN DECREASED 101
161 PSYCHOMOTOR HYPERACTIVITY 100
162 EATING DISORDER 99
163 WRONG TECHNIQUE IN DRUG USAGE PROCESS 99
164 CEREBRAL HAEMORRHAGE 98
165 MEDICATION ERROR 98
166 SALIVARY HYPERSECRETION 98
167 ADVERSE DRUG REACTION 94
168 COMA 94
169 DEVICE OCCLUSION 94
170 NERVOUSNESS 93
171 NASOPHARYNGITIS 92
172 WHITE BLOOD CELL COUNT INCREASED 92
173 RECTAL HAEMORRHAGE 91
174 NO ADVERSE EVENT 90
175 SEDATION 88
176 EPILEPSY 87
177 IRRITABILITY 87
178 PALLOR 86
179 MENTAL DISORDER 85
180 BLOOD GLUCOSE INCREASED 83
181 ASPIRATION 82
182 CHOKING 82
183 BEDRIDDEN 81
184 MOTOR DYSFUNCTION 81
185 PARAESTHESIA 81
186 STRESS 81
187 CARDIAC FAILURE CONGESTIVE 80
188 FEEDING DISORDER 80
189 C-REACTIVE PROTEIN INCREASED 79
190 RENAL FAILURE ACUTE 79
191 TACHYCARDIA 79
192 ANGER 78
193 BLOOD CREATININE INCREASED 78
194 DYSPHONIA 78
195 HEART RATE DECREASED 77
196 THROMBOCYTOPENIA 77
197 HAEMATEMESIS 76
198 SKIN IRRITATION 76
199 VISUAL IMPAIRMENT 76
200 AKINESIA 75
201 MENTAL IMPAIRMENT 75
202 PANCREATITIS 75
203 PRODUCTIVE COUGH 75
204 FEAR 74
205 MIDDLE INSOMNIA 73
206 PRESCRIBED UNDERDOSE 73
207 BLOOD PRESSURE FLUCTUATION 72
208 CHILLS 72
209 NOCTURIA 72
210 DECUBITUS ULCER 71
211 HAEMORRHAGE 71
212 HALLUCINATION, AUDITORY 71
213 ILLNESS 71
214 JOINT SWELLING 71
215 RESPIRATORY ARREST 71
216 APATHY 70
217 DEMENTIA WITH LEWY BODIES 70
218 HYPOGLYCAEMIA 70
219 INFARCTION 70
220 INTERNATIONAL NORMALISED RATIO INCREASED 70
221 POLLAKIURIA 70
222 STOMA SITE PAIN 70
223 DYSPEPSIA 69
224 EXTRAPYRAMIDAL DISORDER 69
225 LUNG DISORDER 69
226 URTICARIA 69
227 ANTICHOLINERGIC SYNDROME 68
228 DRY MOUTH 68
229 PARKINSON'S DISEASE 68
230 BLISTER 67
231 ALTERED STATE OF CONSCIOUSNESS 66
232 APPLICATION SITE IRRITATION 66
233 CRYING 66
234 DEVICE DIFFICULT TO USE 66
235 HYPOAESTHESIA 66
236 MULTI-ORGAN FAILURE 66
237 POSTURE ABNORMAL 66
238 ASTHMA 65
239 INFLUENZA 65
240 OSTEOARTHRITIS 65
241 APPLICATION SITE HYPERSENSITIVITY 64
242 INCONTINENCE 64
243 MENTAL STATUS CHANGES 64
244 NEUROLEPTIC MALIGNANT SYNDROME 64
245 POOR QUALITY SLEEP 64
246 TENSION 64
247 CATARACT 63
248 EPISTAXIS 63
249 SINUS BRADYCARDIA 63
250 VERTIGO 63
251 ELECTROCARDIOGRAM QT PROLONGED 62
252 HALLUCINATIONS, MIXED 62
253 RIB FRACTURE 62
254 TERMINAL STATE 62
255 CYSTITIS 60
256 DRUG DOSE OMISSION 60
257 OXYGEN SATURATION DECREASED 60
258 SUICIDAL IDEATION 60
259 THERAPEUTIC PRODUCT EFFECT DECREASED 60
260 CEREBRAL INFARCTION 59
261 CIRCULATORY COLLAPSE 59
262 DRUG HYPERSENSITIVITY 59
263 INCOHERENT 59
264 SCREAMING 59
265 HEART RATE INCREASED 58
266 RHABDOMYOLYSIS 58
267 SEPTIC SHOCK 58
268 THERAPEUTIC PRODUCT EFFECT VARIABLE 58
269 NONSPECIFIC REACTION 57
270 STOMA SITE REACTION 57
271 THROMBOSIS 57
272 FLUID INTAKE REDUCED 56
273 HYPERKALAEMIA 56
274 PLEURAL EFFUSION 56
275 PULMONARY OEDEMA 56
276 BRONCHITIS 55
277 FIBROMA 55
278 RESPIRATORY TRACT INFECTION 55
279 CEREBRAL ATROPHY 54
280 FAECALOMA 54
281 MALNUTRITION 53
282 GASTRITIS 52
283 HAEMATOMA 52
284 RENAL IMPAIRMENT 51
285 STOMA SITE INFECTION 51
286 THERAPEUTIC RESPONSE UNEXPECTED 51
287 SUBDURAL HAEMATOMA 50
288 ACCIDENTAL OVERDOSE 49
289 DRUG ADMINISTRATION ERROR 49
290 LOWER LIMB FRACTURE 49
291 PRODUCT ADMINISTRATION ERROR 49
292 RENAL DISORDER 49
293 SKIN DISCOLOURATION 49
294 DROOLING 48
295 FLATULENCE 48
296 HYPOKALAEMIA 48
297 ILL-DEFINED DISORDER 48
298 MIOSIS 48
299 MOOD ALTERED 48
300 THERAPEUTIC RESPONSE SHORTENED 48
301 INFLAMMATION 47
302 INJURY 47
303 ACTIVITIES OF DAILY LIVING IMPAIRED 46
304 BLOOD CREATINE PHOSPHOKINASE INCREASED 46
305 FEMORAL NECK FRACTURE 46
306 ILEUS 46
307 PRODUCT SUBSTITUTION ISSUE 46
308 SWELLING 46
309 VISION BLURRED 46
310 WOUND 46
311 ANAL INCONTINENCE 45
312 ANOREXIA 45
313 COMMUNICATION DISORDER 45
314 DEVICE BREAKAGE 45
315 HAEMATOCHEZIA 45
316 NEOPLASM MALIGNANT 45
317 PRODUCT AVAILABILITY ISSUE 45
318 PRODUCT DOSE OMISSION 45
319 TREATMENT NONCOMPLIANCE 45
320 ABNORMAL FAECES 44
321 APPLICATION SITE REACTION 44
322 NECK PAIN 44
323 REHABILITATION THERAPY 44
324 STOMA SITE INFLAMMATION 44
325 APPLICATION SITE PAIN 43
326 DIZZINESS POSTURAL 43
327 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 43
328 GASTRIC ULCER 43
329 PALPITATIONS 43
330 REDUCED FACIAL EXPRESSION 43
331 SURGERY 43
332 ARTHRITIS 42
333 ATRIOVENTRICULAR BLOCK 42
334 BLOOD UREA INCREASED 42
335 DRY SKIN 42
336 INTESTINAL OBSTRUCTION 42
337 MOOD SWINGS 42
338 MYOCLONUS 42
339 PRESYNCOPE 42
340 PRODUCT SUPPLY ISSUE 42
341 SUBILEUS 42
342 THINKING ABNORMAL 42
343 ASPARTATE AMINOTRANSFERASE INCREASED 41
344 BLOOD PRESSURE ABNORMAL 41
345 DEVICE LEAKAGE 41
346 DYSURIA 41
347 GASTRIC DISORDER 41
348 LEUKOCYTOSIS 41
349 CHEST DISCOMFORT 40
350 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40
351 DISCOMFORT 40
352 HEART RATE IRREGULAR 40
353 INITIAL INSOMNIA 40
354 LACTIC ACIDOSIS 40
355 OSTEOPOROSIS 40
356 ACUTE MYOCARDIAL INFARCTION 39
357 CHOLELITHIASIS 39
358 GASTROOESOPHAGEAL REFLUX DISEASE 39
359 RETCHING 39
360 ALANINE AMINOTRANSFERASE INCREASED 38
361 DEEP VEIN THROMBOSIS 38
362 DERMATITIS CONTACT 38
363 DYSCHEZIA 38
364 HOSPICE CARE 38
365 NERVOUS SYSTEM DISORDER 38
366 OEDEMA 38
367 PRODUCT QUALITY ISSUE 38
368 RHINORRHOEA 38
369 STOMA SITE HYPERGRANULATION 38
370 UPPER LIMB FRACTURE 38
371 CHRONIC KIDNEY DISEASE 37
372 COLD SWEAT 37
373 HYPERGLYCAEMIA 37
374 HYPOACUSIS 37
375 PLATELET COUNT DECREASED 37
376 BLADDER DISORDER 36
377 BLOOD POTASSIUM DECREASED 36
378 CLAVICLE FRACTURE 36
379 CONCOMITANT DISEASE AGGRAVATED 36
380 LUNG INFECTION 36
381 MANIA 36
382 MELAENA 36
383 OBSESSIVE-COMPULSIVE DISORDER 36
384 PARALYSIS 36
385 PRODUCT PRESCRIBING ERROR 36
386 BOWEL MOVEMENT IRREGULARITY 35
387 CATATONIA 35
388 DEAFNESS 35
389 EMBEDDED DEVICE 35
390 FAECES DISCOLOURED 35
391 HEMIPLEGIA 35
392 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35
393 MUSCLE TWITCHING 35
394 MYALGIA 35
395 RESPIRATORY DISORDER 35
396 SKIN EXFOLIATION 35
397 STOMA SITE IRRITATION 35
398 SWELLING FACE 35
399 WITHDRAWAL SYNDROME 35
400 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35
401 BEHAVIOUR DISORDER 34
402 CELLULITIS 34
403 COORDINATION ABNORMAL 34
404 EMOTIONAL DISTRESS 34
405 HEMIPARESIS 34
406 HYPOXIA 34
407 JOINT INJURY 34
408 NASAL CONGESTION 34
409 AKATHISIA 33
410 BLOOD PRESSURE SYSTOLIC INCREASED 33
411 CARDIOMEGALY 33
412 CHROMATURIA 33
413 DEVICE KINK 33
414 EMOTIONAL DISORDER 33
415 GASTROINTESTINAL SOUNDS ABNORMAL 33
416 HYPERTENSIVE CRISIS 33
417 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33
418 NEPHROLITHIASIS 33
419 STOMA SITE HAEMORRHAGE 33
420 WHEELCHAIR USER 33
421 APPLICATION SITE VESICLES 32
422 DEVICE USE ERROR 32
423 DIVERTICULITIS 32
424 FRACTURE 32
425 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32
426 LIMB DISCOMFORT 32
427 VITAMIN B12 DEFICIENCY 32
428 ABDOMINAL TENDERNESS 31
429 CHOLINERGIC SYNDROME 31
430 DEVICE ALARM ISSUE 31
431 DIPLOPIA 31
432 HAEMATURIA 31
433 HEAD DISCOMFORT 31
434 HEPATITIS 31
435 HYPOTONIA 31
436 NEUROPATHY PERIPHERAL 31
437 PEMPHIGOID 31
438 RASH ERYTHEMATOUS 31
439 SKIN REACTION 31
440 APPARENT DEATH 30
441 APPLICATION SITE SWELLING 30
442 BLOOD ALKALINE PHOSPHATASE INCREASED 30
443 BRADYPHRENIA 30
444 DEVICE CONNECTION ISSUE 30
445 ENCEPHALOPATHY 30
446 FLUID RETENTION 30
447 HAEMATOCRIT DECREASED 30
448 HYPERNATRAEMIA 30
449 INTENTIONAL OVERDOSE 30
450 LIMB INJURY 30
451 PARKINSON^S DISEASE PSYCHOSIS 30
452 PELVIC FRACTURE 30
453 SOPOR 30
454 SPINAL FRACTURE 30
455 UPPER GASTROINTESTINAL HAEMORRHAGE 30
456 VASCULAR ENCEPHALOPATHY 30
457 WHEEZING 30
458 ADVERSE EVENT 29
459 AMYLOID RELATED IMAGING ABNORMALITY-OEDEMA/EFFUSION 29
460 APPETITE DISORDER 29
461 ATRIOVENTRICULAR BLOCK COMPLETE 29
462 BLOOD CHOLESTEROL INCREASED 29
463 BLOOD SODIUM DECREASED 29
464 BURNING SENSATION 29
465 EXTRA DOSE ADMINISTERED 29
466 FAECAL INCONTINENCE 29
467 GASTROENTERITIS 29
468 HAEMORRHAGIC STROKE 29
469 HEPATIC ENZYME INCREASED 29
470 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 29
471 PRODUCT RESIDUE PRESENT 29
472 RESPIRATORY DISTRESS 29
473 RESTLESS LEGS SYNDROME 29
474 SUDDEN DEATH 29
475 THERAPY CESSATION 29
476 TINNITUS 29
477 WRIST FRACTURE 29
478 BODY HEIGHT DECREASED 28
479 DERMATITIS BULLOUS 28
480 HIATUS HERNIA 28
481 IMMOBILE 28
482 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 28
483 JAUNDICE 28
484 LEUKOPENIA 28
485 LIVER DISORDER 28
486 LOWER RESPIRATORY TRACT INFECTION 28
487 MIGRAINE 28
488 SKIN LESION 28
489 WHITE BLOOD CELL COUNT DECREASED 28
490 ANGIOEDEMA 27
491 BLOOD CHOLINESTERASE DECREASED 27
492 CARDIOVASCULAR DISORDER 27
493 DEVICE USE ISSUE 27
494 ELECTROCARDIOGRAM ABNORMAL 27
495 FAECES HARD 27
496 FUNGAL INFECTION 27
497 HERPES ZOSTER 27
498 INFLUENZA LIKE ILLNESS 27
499 LOGORRHOEA 27
500 PERIPHERAL COLDNESS 27
501 PRESCRIBED OVERDOSE 27
502 PRODUCT ADMINISTRATION INTERRUPTED 27
503 RASH MACULAR 27
504 RASH PRURITIC 27
505 SPUTUM INCREASED 27
506 THERAPY INTERRUPTED 27
507 WRONG PRODUCT ADMINISTERED 27
508 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 26
509 FACIAL BONES FRACTURE 26
510 INTERSTITIAL LUNG DISEASE 26
511 ISCHAEMIC STROKE 26
512 NEUTROPENIA 26
513 PANIC REACTION 26
514 SENILE DEMENTIA 26
515 TEMPERATURE INTOLERANCE 26
516 VIRAL INFECTION 26
517 ACUTE RESPIRATORY FAILURE 25
518 BRONCHOPNEUMONIA 25
519 CEREBRAL ISCHAEMIA 25
520 COMPLETED SUICIDE 25
521 CYANOSIS 25
522 IMPAIRED QUALITY OF LIFE 25
523 JOINT WARMTH 25
524 PANCREATITIS ACUTE 25
525 PHOTOSENSITIVITY REACTION 25
526 PLEUROTHOTONUS 25
527 PROSTATE CANCER 25
528 RHINITIS ALLERGIC 25
529 SKIN LACERATION 25
530 THERAPY NON-RESPONDER 25
531 UROSEPSIS 25
532 BLOOD SODIUM INCREASED 24
533 BREAST CANCER 24
534 CARDIAC PACEMAKER INSERTION 24
535 INFREQUENT BOWEL MOVEMENTS 24
536 NASAL POLYPS 24
537 NEUTROPHIL COUNT INCREASED 24
538 ALOPECIA 23
539 APHAGIA 23
540 BLINDNESS 23
541 CHOLESTASIS 23
542 DAYDREAMING 23
543 DECREASED ACTIVITY 23
544 ENTERAL NUTRITION 23
545 HIP SURGERY 23
546 HYPOTHERMIA 23
547 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 23
548 JOINT DISLOCATION 23
549 MUSCULOSKELETAL PAIN 23
550 PARKINSONIAN GAIT 23
551 SINUSITIS 23
552 SKIN DISORDER 23
553 STATUS EPILEPTICUS 23
554 THERAPEUTIC RESPONSE DECREASED 23
555 VENTRICULAR EXTRASYSTOLES 23
556 ARTHROPATHY 22
557 CACHEXIA 22
558 CLOSTRIDIUM DIFFICILE INFECTION 22
559 COGWHEEL RIGIDITY 22
560 DRUG PRESCRIBING ERROR 22
561 DUODENAL ULCER 22
562 ECZEMA 22
563 FINE MOTOR SKILL DYSFUNCTION 22
564 FLUSHING 22
565 GASTRIC HAEMORRHAGE 22
566 GENERAL PHYSICAL CONDITION ABNORMAL 22
567 HYPOTHYROIDISM 22
568 ILLUSION 22
569 LUNG NEOPLASM MALIGNANT 22
570 MITRAL VALVE INCOMPETENCE 22
571 ORAL PAIN 22
572 PANIC ATTACK 22
573 PARADOXICAL DRUG REACTION 22
574 SECRETION DISCHARGE 22
575 SENSORY DISTURBANCE 22
576 SLEEP APNOEA SYNDROME 22
577 STOMA SITE EXTRAVASATION 22
578 TACHYPNOEA 22
579 TOXIC SKIN ERUPTION 22
580 ULCER 22
581 UNINTENTIONAL MEDICAL DEVICE REMOVAL 22
582 APRAXIA 21
583 BLOOD URINE PRESENT 21
584 COLITIS 21
585 DERMATITIS ALLERGIC 21
586 FEELING COLD 21
587 GRAND MAL CONVULSION 21
588 IMPAIRED HEALING 21
589 INTENTIONAL PRODUCT MISUSE 21
590 KIDNEY INFECTION 21
591 MUSCULOSKELETAL DISORDER 21
592 PANCREATIC CARCINOMA 21
593 PRODUCT DOSE OMISSION IN ERROR 21
594 SOMNAMBULISM 21
595 STOMA SITE DISCOMFORT 21
596 SUSPICIOUSNESS 21
597 TRANSAMINASES INCREASED 21
598 ANGINA PECTORIS 20
599 APPLICATION SITE DISCOLOURATION 20
600 ATRIOVENTRICULAR BLOCK SECOND DEGREE 20
601 BLOOD GLUCOSE DECREASED 20
602 CORONARY ARTERY DISEASE 20
603 DEFAECATION URGENCY 20
604 EYE DISORDER 20
605 FEELING HOT 20
606 GASTROINTESTINAL INFECTION 20
607 HYPERSEXUALITY 20
608 INFUSION SITE ERYTHEMA 20
609 METABOLIC ACIDOSIS 20
610 OROPHARYNGEAL PAIN 20
611 REBOUND EFFECT 20
612 SHOCK 20
613 TASTE DISORDER 20
614 UPPER RESPIRATORY TRACT INFECTION 20
615 VASCULAR DEMENTIA 20
616 ANOSMIA 19
617 BODY TEMPERATURE INCREASED 19
618 EYE MOVEMENT DISORDER 19
619 FAILURE TO THRIVE 19
620 FREQUENT BOWEL MOVEMENTS 19
621 HANGOVER 19
622 LIVER FUNCTION TEST ABNORMAL 19
623 LYMPHOEDEMA 19
624 NOSOCOMIAL INFECTION 19
625 PANCYTOPENIA 19
626 RASH MACULO-PAPULAR 19
627 ROAD TRAFFIC ACCIDENT 19
628 SCRATCH 19
629 SKIN ABRASION 19
630 SWOLLEN TONGUE 19
631 TYPE 2 DIABETES MELLITUS 19
632 AGRANULOCYTOSIS 18
633 ARTERIOSCLEROSIS 18
634 BLOOD POTASSIUM INCREASED 18
635 BUNDLE BRANCH BLOCK LEFT 18
636 CEREBELLAR ATROPHY 18
637 CYTOLYTIC HEPATITIS 18
638 DERMATITIS 18
639 DIABETES MELLITUS INADEQUATE CONTROL 18
640 DYSENTERY 18
641 DYSGRAPHIA 18
642 ELECTROLYTE IMBALANCE 18
643 FOOT DEFORMITY 18
644 HIP ARTHROPLASTY 18
645 INFUSION RELATED REACTION 18
646 INTENTIONAL PRODUCT USE ISSUE 18
647 PRODUCT PHYSICAL ISSUE 18
648 RESTING TREMOR 18
649 SKIN HAEMORRHAGE 18
650 SLEEP TALKING 18
651 SOCIAL AVOIDANT BEHAVIOUR 18
652 STUPOR 18
653 SUICIDE ATTEMPT 18
654 TORTICOLLIS 18
655 ACCIDENT 17
656 ATELECTASIS 17
657 AUTONOMIC NERVOUS SYSTEM IMBALANCE 17
658 BENIGN PROSTATIC HYPERPLASIA 17
659 BONE PAIN 17
660 BRAIN OEDEMA 17
661 COLON CANCER 17
662 CONCOMITANT DISEASE PROGRESSION 17
663 DRUG DEPENDENCE 17
664 DRUG EFFECT INCOMPLETE 17
665 FOOD REFUSAL 17
666 HAND FRACTURE 17
667 HERNIA 17
668 HOT FLUSH 17
669 HYDROCEPHALUS 17
670 HYPERCALCAEMIA 17
671 HYPERVENTILATION 17
672 ISCHAEMIA 17
673 LACERATION 17
674 LACRIMATION INCREASED 17
675 MICTURITION URGENCY 17
676 NIGHT SWEATS 17
677 PETIT MAL EPILEPSY 17
678 PRODUCT USE COMPLAINT 17
679 PSYCHIATRIC SYMPTOM 17
680 PURPURA 17
681 QUALITY OF LIFE DECREASED 17
682 RALES 17
683 SEXUAL DYSFUNCTION 17
684 SKIN ULCER 17
685 SLUGGISHNESS 17
686 STOMA COMPLICATION 17
687 TORSADE DE POINTES 17
688 TREATMENT FAILURE 17
689 WOUND INFECTION 17
690 APNOEA 16
691 ASPIRATION BRONCHIAL 16
692 BODY TEMPERATURE DECREASED 16
693 CRANIOCEREBRAL INJURY 16
694 CREATININE RENAL CLEARANCE DECREASED 16
695 DEVICE PHYSICAL PROPERTY ISSUE 16
696 DRUG EFFECT DECREASED 16
697 DYSGEUSIA 16
698 EMPHYSEMA 16
699 EOSINOPHILIA 16
700 EYELID FUNCTION DISORDER 16
701 GASTROINTESTINAL TUBE INSERTION 16
702 GENERALISED TONIC-CLONIC SEIZURE 16
703 GRIMACING 16
704 HUMERUS FRACTURE 16
705 HYPERTONIA 16
706 HYPORESPONSIVE TO STIMULI 16
707 INCORRECT DRUG ADMINISTRATION DURATION 16
708 INFUSION SITE INDURATION 16
709 INJECTION SITE PAIN 16
710 LANGUAGE DISORDER 16
711 MULTIPLE SCLEROSIS 16
712 POTENTIATING DRUG INTERACTION 16
713 PROSTATOMEGALY 16
714 PRURITUS GENERALISED 16
715 PSYCHOTIC SYMPTOM 16
716 RASH GENERALISED 16
717 RASH PAPULAR 16
718 REPETITIVE SPEECH 16
719 STEVENS-JOHNSON SYNDROME 16
720 STOMATITIS 16
721 THERAPEUTIC PRODUCT EFFECT DELAYED 16
722 VENTRICULAR TACHYCARDIA 16
723 WALKING AID USER 16
724 ACCIDENTAL EXPOSURE 15
725 CARDIOPULMONARY FAILURE 15
726 CEREBRAL HAEMATOMA 15
727 CLONUS 15
728 CLOSTRIDIUM DIFFICILE COLITIS 15
729 GASTROSTOMY 15
730 GLAUCOMA 15
731 HAEMORRHAGE INTRACRANIAL 15
732 IMPAIRED SELF-CARE 15
733 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15
734 INCREASED APPETITE 15
735 LOWER GASTROINTESTINAL HAEMORRHAGE 15
736 OESOPHAGITIS 15
737 PERSONALITY CHANGE 15
738 PSYCHOTIC BEHAVIOUR 15
739 RED BLOOD CELL COUNT DECREASED 15
740 SCHIZOPHRENIA 15
741 STOMA SITE ODOUR 15
742 THROAT IRRITATION 15
743 AGNOSIA 14
744 BACTERIAL INFECTION 14
745 BLADDER CATHETERISATION 14
746 BLOOD IRON DECREASED 14
747 BUNDLE BRANCH BLOCK RIGHT 14
748 DRUG WITHDRAWAL SYNDROME 14
749 EMBOLISM 14
750 EUTHANASIA 14
751 GALLBLADDER DISORDER 14
752 GASTROINTESTINAL MOTILITY DISORDER 14
753 HEPATIC CIRRHOSIS 14
754 IMPULSE-CONTROL DISORDER 14
755 INCORRECT ROUTE OF DRUG ADMINISTRATION 14
756 LABYRINTHITIS 14
757 LISTLESS 14
758 LIVING IN RESIDENTIAL INSTITUTION 14
759 LYMPHOCYTE COUNT DECREASED 14
760 MACULAR DEGENERATION 14
761 MINI MENTAL STATUS EXAMINATION ABNORMAL 14
762 MYELODYSPLASTIC SYNDROME 14
763 OCULAR HYPERAEMIA 14
764 OSTEOPENIA 14
765 PARTIAL SEIZURES 14
766 PERSECUTORY DELUSION 14
767 SCAR 14
768 SINUS ARREST 14
769 SINUS TACHYCARDIA 14
770 VARICOSE VEIN 14
771 WHITE BLOOD CELLS URINE POSITIVE 14
772 ACCIDENTAL EXPOSURE TO PRODUCT 13
773 AFFECTIVE DISORDER 13
774 AGEUSIA 13
775 APPLICATION SITE INFLAMMATION 13
776 ATRIAL FLUTTER 13
777 BACK INJURY 13
778 BLOOD BILIRUBIN INCREASED 13
779 CARDIOMYOPATHY 13
780 CEREBRAL DISORDER 13
781 CORONAVIRUS INFECTION 13
782 DRUG TOXICITY 13
783 FACIAL PARALYSIS 13
784 FOOT FRACTURE 13
785 HALLUCINATION, TACTILE 13
786 HEPATIC FUNCTION ABNORMAL 13
787 HEPATOCELLULAR INJURY 13
788 HICCUPS 13
789 HYPERTHERMIA 13
790 IRON DEFICIENCY ANAEMIA 13
791 LIPASE INCREASED 13
792 MULTIPLE FRACTURES 13
793 MYDRIASIS 13
794 PARESIS 13
795 POISONING 13
796 SEROTONIN SYNDROME 13
797 SKIN CANCER 13
798 STAPHYLOCOCCAL INFECTION 13
799 URINE OUTPUT DECREASED 13
800 APPLICATION SITE DERMATITIS 12
801 ATAXIA 12
802 ATRIOVENTRICULAR BLOCK FIRST DEGREE 12
803 BACK DISORDER 12
804 BIPOLAR DISORDER 12
805 BLOOD ALBUMIN DECREASED 12
806 CONTRAINDICATED PRODUCT ADMINISTERED 12
807 CROHN^S DISEASE 12
808 DISEASE RECURRENCE 12
809 DRUG LEVEL INCREASED 12
810 DRUG-INDUCED LIVER INJURY 12
811 DYSPNOEA EXERTIONAL 12
812 ENURESIS 12
813 ERUCTATION 12
814 ESCHAR 12
815 ESCHERICHIA URINARY TRACT INFECTION 12
816 EYE PAIN 12
817 FEBRILE NEUTROPENIA 12
818 FOOD INTOLERANCE 12
819 GASTRIC CANCER 12
820 GASTRIC ULCER HAEMORRHAGE 12
821 HAEMOPTYSIS 12
822 HAEMORRHAGIC ANAEMIA 12
823 IMPAIRED GASTRIC EMPTYING 12
824 INCORRECT PRODUCT ADMINISTRATION DURATION 12
825 INFUSION SITE SWELLING 12
826 INTESTINAL HAEMORRHAGE 12
827 LIBIDO INCREASED 12
828 LOCALISED INFECTION 12
829 LUNG INFILTRATION 12
830 MASTICATION DISORDER 12
831 MUSCLE ATROPHY 12
832 MUSCLE CONTRACTIONS INVOLUNTARY 12
833 MUSCLE CONTRACTURE 12
834 NEURALGIA 12
835 NODULE 12
836 OSTEOMYELITIS 12
837 OXYGEN SATURATION ABNORMAL 12
838 PALLIATIVE CARE 12
839 PERICARDIAL EFFUSION 12
840 PERITONITIS 12
841 POLYPECTOMY 12
842 PROSTATIC DISORDER 12
843 PULMONARY CONGESTION 12
844 RHEUMATOID ARTHRITIS 12
845 SLOW SPEECH 12
846 SPINAL COLUMN INJURY 12
847 UNDERWEIGHT 12
848 VISUAL ACUITY REDUCED 12
849 WOUND COMPLICATION 12
850 ANKLE FRACTURE 11
851 AORTIC ANEURYSM 11
852 APHTHOUS ULCER 11
853 BLOOD CALCIUM INCREASED 11
854 BLOOD GLUCOSE FLUCTUATION 11
855 BLOOD LACTATE DEHYDROGENASE INCREASED 11
856 BLOOD PRESSURE INADEQUATELY CONTROLLED 11
857 BONE DISORDER 11
858 CARDIOGENIC SHOCK 11
859 CATARACT OPERATION 11
860 CEREBRAL THROMBOSIS 11
861 CHOLECYSTITIS 11
862 COAGULOPATHY 11
863 COMPLICATION ASSOCIATED WITH DEVICE 11
864 COMPULSIONS 11
865 DISINHIBITION 11
866 DRUG DISPENSING ERROR 11
867 DRUG ERUPTION 11
868 DRUG TOLERANCE 11
869 END STAGE RENAL DISEASE 11
870 ERYSIPELAS 11
871 EUPHORIC MOOD 11
872 EXCORIATION 11
873 FACE OEDEMA 11
874 FEELING JITTERY 11
875 FRONTOTEMPORAL DEMENTIA 11
876 GASTROENTERITIS VIRAL 11
877 HAEMORRHOIDS 11
878 HAND DEFORMITY 11
879 HYPERLIPIDAEMIA 11
880 INCREASED BRONCHIAL SECRETION 11
881 INFUSION SITE INFECTION 11
882 INFUSION SITE PAIN 11
883 INFUSION SITE REACTION 11
884 INTENTIONAL DOSE OMISSION 11
885 INTENTIONAL UNDERDOSE 11
886 LABORATORY TEST ABNORMAL 11
887 LACK OF SPONTANEOUS SPEECH 11
888 MEDICAL DEVICE DISCOMFORT 11
889 MUSCLE DISORDER 11
890 MUSCULOSKELETAL CHEST PAIN 11
891 PANIC DISORDER 11
892 PATIENT ELOPEMENT 11
893 POLYMYALGIA RHEUMATICA 11
894 POLYNEUROPATHY 11
895 PROTHROMBIN TIME PROLONGED 11
896 PSYCHOMOTOR SKILLS IMPAIRED 11
897 REFUSAL OF TREATMENT BY PATIENT 11
898 SICK SINUS SYNDROME 11
899 SKIN BURNING SENSATION 11
900 SLEEP TERROR 11
901 SPINAL COMPRESSION FRACTURE 11
902 STARING 11
903 STOMA SITE INDURATION 11
904 THERAPY PARTIAL RESPONDER 11
905 TOBACCO INTERACTION 11
906 TOOTH FRACTURE 11
907 TROPONIN INCREASED 11
908 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 11
909 URINARY CASTS PRESENT 11
910 VITAMIN D DEFICIENCY 11
911 VOLVULUS 11
912 WEIGHT FLUCTUATION 11
913 ANAPHYLACTIC REACTION 10
914 ASPHYXIA 10
915 BASAL GANGLIA INFARCTION 10
916 BLADDER CANCER 10
917 CARDIAC MURMUR 10
918 COLITIS ULCERATIVE 10
919 CONJUNCTIVITIS 10
920 DELUSIONAL DISORDER, UNSPECIFIED TYPE 10
921 DEVICE PLACEMENT ISSUE 10
922 DEVICE RELATED INFECTION 10
923 DIABETIC COMPLICATION 10
924 DRUG ABUSE 10
925 DRUG RESISTANCE 10
926 DYSPHEMIA 10
927 EOSINOPHIL COUNT INCREASED 10
928 EYE SWELLING 10
929 GASTROINTESTINAL PAIN 10
930 GENERAL SYMPTOM 10
931 HEPATIC NEOPLASM MALIGNANT 10
932 HYPOALBUMINAEMIA 10
933 HYPOVOLAEMIA 10
934 IMPULSIVE BEHAVIOUR 10
935 INCORRECT DOSE ADMINISTERED BY DEVICE 10
936 INCORRECT DOSE ADMINISTERED BY PRODUCT 10
937 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 10
938 INFUSION SITE NODULE 10
939 INJECTION SITE BRUISING 10
940 INJECTION SITE HAEMORRHAGE 10
941 INTERNAL HAEMORRHAGE 10
942 JOINT RANGE OF MOTION DECREASED 10
943 LACUNAR INFARCTION 10
944 LOCAL SWELLING 10
945 MALIGNANT NEOPLASM PROGRESSION 10
946 MEDICAL DEVICE CHANGE 10
947 MEDICAL DEVICE SITE DRYNESS 10
948 MICTURITION DISORDER 10
949 MULTIPLE SCLEROSIS RELAPSE 10
950 MUSCLE TIGHTNESS 10
951 NEPHROGENIC ANAEMIA 10
952 NEURODEGENERATIVE DISORDER 10
953 PERONEAL NERVE PALSY 10
954 POST PROCEDURAL COMPLICATION 10
955 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 10
956 PRODUCT DISPENSING ERROR 10
957 PRODUCT PRESCRIBING ISSUE 10
958 PULMONARY FIBROSIS 10
959 PURULENT DISCHARGE 10
960 PYELONEPHRITIS 10
961 RENAL CYST 10
962 RENAL FAILURE CHRONIC 10
963 RENAL INJURY 10
964 RESPIRATORY RATE INCREASED 10
965 SHOCK HAEMORRHAGIC 10
966 SLOW RESPONSE TO STIMULI 10
967 SPUTUM DISCOLOURED 10
968 SQUAMOUS CELL CARCINOMA 10
969 SUPRAVENTRICULAR EXTRASYSTOLES 10
970 SUSPECTED COVID-19 10
971 TARDIVE DYSKINESIA 10
972 TOOTH DISORDER 10
973 TOOTH LOSS 10
974 URINE ODOUR ABNORMAL 10
975 VAGINAL HAEMORRHAGE 10
976 WALKING DISABILITY 10
977 ACUTE CORONARY SYNDROME 9
978 ACUTE PULMONARY OEDEMA 9
979 ANAEMIA MACROCYTIC 9
980 ANEURYSM 9
981 ATROPHY 9
982 BASAL CELL CARCINOMA 9
983 BLOOD TEST ABNORMAL 9
984 BRADYARRHYTHMIA 9
985 CARDIOACTIVE DRUG LEVEL INCREASED 9
986 CATHETER SITE ERYTHEMA 9
987 COMPUTERISED TOMOGRAM ABNORMAL 9
988 CONCUSSION 9
989 CORONARY ARTERY THROMBOSIS 9
990 DECREASED INTEREST 9
991 DEPENDENCE 9
992 DIET REFUSAL 9
993 DISSOCIATION 9
994 DRUG EFFECT LESS THAN EXPECTED 9
995 ECONOMIC PROBLEM 9
996 ERYTHEMA MULTIFORME 9
997 EXPIRED PRODUCT ADMINISTERED 9
998 FACE INJURY 9
999 FIBROMYALGIA 9